175 related articles for article (PubMed ID: 560124)
1. Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer model.
Knapp RC; Berkowitz RS
Am J Obstet Gynecol; 1977 Aug; 128(7):782-6. PubMed ID: 560124
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity.
Bast RC; Knapp RC; Mitchell AK; Thurston JG; Tucker RW; Schlossman SF
J Immunol; 1979 Nov; 123(5):1945-51. PubMed ID: 489967
[TBL] [Abstract][Full Text] [Related]
3. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer.
Vanhaelen CP; Fisher RI
Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085
[TBL] [Abstract][Full Text] [Related]
4. Rejection of murine ovarian cancer following treatment with regional immunotherapy: correlations with a neutrophil-mediated activation of cytostatic macrophages.
Lichtenstein A
Cell Immunol; 1985 Sep; 94(2):521-35. PubMed ID: 4028167
[TBL] [Abstract][Full Text] [Related]
5. Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.
O'Neill GJ; Stebbing N
Br J Cancer; 1980 Feb; 41(2):243-9. PubMed ID: 7370164
[TBL] [Abstract][Full Text] [Related]
6. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.
Bast RC; Berek JS; Obrist R; Griffiths CT; Berkowitz RS; Hacker NF; Parker L; Lagasse LD; Knapp RC
Cancer Res; 1983 Mar; 43(3):1395-401. PubMed ID: 6825108
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
Dye ES; North RJ; Mills CD
J Exp Med; 1981 Sep; 154(3):609-20. PubMed ID: 6974214
[TBL] [Abstract][Full Text] [Related]
9. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation.
Suit HD; Sedlacek R; Silobrcic V
Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026
[No Abstract] [Full Text] [Related]
10. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
Kiya K; Toge T; Harada K; Uozumi T; Hattori T
Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
[TBL] [Abstract][Full Text] [Related]
11. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
[No Abstract] [Full Text] [Related]
12. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. I. Variation in administration of both agents.
Fisher B; Wolmark N; Rubin H; Saffer E
J Natl Cancer Inst; 1975 Nov; 55(5):1147-53. PubMed ID: 1206740
[TBL] [Abstract][Full Text] [Related]
13. Serologic immunotherapy: results and probable mechanism of action.
Order SE; Kirkman R; Knapp R
Cancer; 1974 Jul; 34(1):175-83. PubMed ID: 4858206
[No Abstract] [Full Text] [Related]
14. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
Woodruff MF; Warner NL
J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
[TBL] [Abstract][Full Text] [Related]
16. Effects of Corynebacterium parvum on murine myeloid leukaemia.
Bjornsson S; Preisler H; Pavelic Z
Br J Cancer; 1978 Dec; 38(6):703-8. PubMed ID: 217398
[TBL] [Abstract][Full Text] [Related]
17. Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum.
Lichtenstein A; Berek J; Bast R; Spina C; Hacker N; Knapp RC; Zighelboim J
J Biol Response Mod; 1984 Aug; 3(4):371-8. PubMed ID: 6541243
[TBL] [Abstract][Full Text] [Related]
18. Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.
Ullrich RL; Adams LM
Radiat Res; 1978 Feb; 73(2):267-73. PubMed ID: 204955
[No Abstract] [Full Text] [Related]
19. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
Scott MT
J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of ovarian carcinoma. An experimental model.
Order SE; Donahue V; Knapp R
Cancer; 1973 Sep; 32(3):573-9. PubMed ID: 4125460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
